Prognostic value of tumor‑associated CD177<sup>+</sup> neutrophils in lung adenocarcinoma

Zhou,Jinhua; Xu,Qingxia; Liu,Huan; Miao,Jianlong; Bian,Cuixia; Wei,Yutao; Wang,Wei; Jiang,Shulong

doi:10.3892/ol.2024.14322

May-2024 Volume 27 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2024 Volume 27 Issue 5

Full Size Image

Article Open Access

Prognostic value of tumor‑associated CD177⁺ neutrophils in lung adenocarcinoma

Authors:
- Jinhua Zhou
- Qingxia Xu
- Huan Liu
- Jianlong Miao
- Cuixia Bian
- Yutao Wei
- Wei Wang
- Shulong Jiang
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Pathology, Jining First People's Hospital, Jining, Shandong 272000, P.R. China, Department of Emergency Internal Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China, Department of Respiratory Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China, Department of Thoracic Surgery, Jining First People's Hospital, Jining, Shandong 272000, P.R. China, Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Clinical Medical Laboratory Center, Jining First People's Hospital, Jining, Shandong 272000, P.R. China

Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 189
|
Published online on: March 1, 2024

https://doi.org/10.3892/ol.2024.14322
Expand metrics +

Abstract

The aim of the present study was to detect CD177⁺ neutrophils in tumor tissues and analyze their association with the clinical characteristics and prognosis of patients with lung adenocarcinoma (LUAD). Immunohistochemistry was used to detect CD177⁺ neutrophils in tumors and adjacent tissues of 16 patients with LUAD who underwent curative surgical resection. A total of 120 patients with LUAD were recruited, and their clinical data were collected; survival follow‑up was performed. CD177⁺ neutrophils in tumor tissues were detected via immunohistochemistry, and the association between CD177⁺ neutrophils and clinical characteristics was analyzed. The density of CD177⁺ neutrophils in tumor tissues and adjacent tissues of patients with LUAD was analyzed using t‑test, and the association between CD177⁺ neutrophils and clinical characteristics was analyzed through the Chi‑square test. Survival was calculated using the Kaplan‑Meier survival rate curve. Finally, the association between these indicators and the survival of LUAD patients was evaluated using Cox regression analysis. CD177⁺ neutrophil infiltration was significantly higher in LUAD tumor tissues, and the high density of CD177⁺ neutrophils was associated with the clinical characteristics of TNM stage, tumor differentiation and poor progression‑free and overall survival in LUAD. In conclusion, tumor‑associated CD177⁺ neutrophils associated with malignant progression and poor prognosis may be independent and unfavorable prognostic biomarkers for LUAD.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Orozco-Morales M, Soca-Chafre G, Bios-Bernal P, Hernández-Pedro N and Arrieta O: Interplay between cellular and molecular inflammatory mediators in lung cancer. Mediators Inflamm. 2016:34946082016. View Article : Google Scholar : PubMed/NCBI
3	Masucci MT, Minopoli M and Carriero MV: Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 9:11462019. View Article : Google Scholar : PubMed/NCBI
4	Dumitru CA, Lang S and Brandau S: Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol. 23:141–148. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kim J and Bae JS: Tumor-Associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI
6	Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, Yin XY and Zheng L: Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 54:948–955. 2011. View Article : Google Scholar : PubMed/NCBI
7	Galdiero MR, Bianchi P, Grizzi F, Di Caro G, Basso G, Ponzetta A, Bonavita E, Barbagallo M, Tartari S, Polentarutti N, et al: Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer. Int J Cancer. 139:446–456. 2016. View Article : Google Scholar : PubMed/NCBI
8	Zhou G, Peng K, Song Y, Yang W, Shu W, Yu T, Yu L, Lin M, Wei Q, Chen C, et al: CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer. Carcinogenesis. 39:272–282. 2018. View Article : Google Scholar : PubMed/NCBI
9	Toyoda T, Tsukamoto T, Yamamoto M, Ban H, Saito N, Takasu S, Shi L, Saito A, Ito S, Yamamura Y, et al: Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: Identification of CD177 as a novel prognostic factor in patients with gastric cancer. BMC Gastroenterol. 13:1222013. View Article : Google Scholar : PubMed/NCBI
10	Jerke U, Rolle S, Dittmar G, Bayat B, Santoso S, Sporbert A, Luft F and Kettritz R: Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation. J Biol Chem. 286:7070–7081. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zhao JJ, Pan K, Wang W, Chen JG, Wu YH, Lv L, Li JJ, Chen YB, Wang DD, Pan QZ, et al: The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One. 7:e336552012. View Article : Google Scholar : PubMed/NCBI
12	Zheng RS, Zhang SW, Sun KX, Chen R, Wang SM, Li L, Zeng HM, Wei WW and He J: Cancer statistics in China, 2016. Zhonghua Zhong Liu Za Zhi. 45:212–220. 2023.(In Chinese). PubMed/NCBI
13	de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, Baz-Dávila R, Zulueta JJ, Aguirre-Jaime A, Saetta M, et al: Lung cancer in patients with chronic obstructive pulmonary disease-incidence and predicting factors. Am J Respir Crit Care Med. 184:913–919. 2011. View Article : Google Scholar : PubMed/NCBI
14	Shaul ME and Fridlender ZG: Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 16:601–620. 2019. View Article : Google Scholar : PubMed/NCBI
15	Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, et al: Baseline neutrophilto-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J Immunother Cancer. 6:742018. View Article : Google Scholar : PubMed/NCBI
16	Zhang Y, Lu JJ, Du YP, Feng CX, Wang LQ and Chen MB: Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine (Baltimore). 97:e1442018.
17	Sebastian NT, Raj R, Prasad R, Barney C, Brownstein J, Grecula J, Haglund K, Xu-Welliver M, Williams TM and Bazan JG: Association of pre-and posttreatment neutrophil-lymphocyte ratio with recurrence and mortality in locally advanced non-small cell lung cancer. Front Oncol. 10:5988732020. View Article : Google Scholar : PubMed/NCBI
18	Wang J, Yibin J, Nana W, Zhang X, Tan B, Zhang G and Cheng Y: The clinical significance of tumorinfiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med. 12:72014. View Article : Google Scholar : PubMed/NCBI
19	Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, Lin WJ and Chang C: Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. Cancer Res. 73:5633–5646. 2013. View Article : Google Scholar : PubMed/NCBI
20	Wang Y, Fang T, Huang L, Wang H, Zhang L, Wang Z and Cui Y: Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochem Biophys Res. 501:313–319. 2018. View Article : Google Scholar : PubMed/NCBI
21	Yang J, Deng M, Bi M, Wang Y, Qiao X and Zhang S: Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer. Future Sci OA. 8:FSO7982022. View Article : Google Scholar : PubMed/NCBI
22	Svaton M, Blazek J, Krakorova G, Buresova M, Teufelova Z, Vodicka J, Hurdalkova K, Barinova M and Pesek M: Laboratory parameters are possible prognostic markers in patients with advanced-stage NSCLC treated with bevacizumab plus chemotherapy. J Cancer. 12:5753–5759. 2021. View Article : Google Scholar : PubMed/NCBI
23	Liu D, Jin J, Zhang L, Li L, Song J and Li W: The neutrophil to lymphocyte ratio may predict benefit from chemotherapy in lung cancer. Cell Physiol Biochem. 46:1595–1605. 2018. View Article : Google Scholar : PubMed/NCBI
24	Punjabi A, Barrett E, Cheng A, Mulla A, Walls G, Johnston D, McAleese J, Moore K, Hicks J, Blyth K, et al: Neutrophil-Lymphocyte ratio and absolute lymphocyte count as prognostic markers in patients treated with curative-intent radiotherapy for non-small cell lung cancer. Clin Oncol (R Coll Radiol). 33:e331–e338. 2021. View Article : Google Scholar : PubMed/NCBI
25	Platini H, Ferdinand E, Kohar K, Prayogo SA, Amirah S, Komariah M and Maulana S: Neutrophil-to-Lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: A systematic review and meta-analysis. Medicina (Kaunas). 58:10692022. View Article : Google Scholar : PubMed/NCBI
26	Coffelt SB, Wellenstein MD and de Visser KE: Neutrophils in cancer:neutral no more. Nat Rev Cancer. 16:443–446. 2016. View Article : Google Scholar : PubMed/NCBI
27	Sionov RV, Fridlender ZG and Granot Z: The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 8:125–158. 2015. View Article : Google Scholar : PubMed/NCBI
28	Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW, et al: Tumor-associated neutrophils stimulate T cell responses in earlystage human lung cancer. J Clin Invest. 124:5466–5480. 2014. View Article : Google Scholar : PubMed/NCBI
29	Carus A, Ladekarl M, Hager H, Pilegaard H, Nielsen PS and Donskov F: Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome. Lung Cancer. 81:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
30	Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coëlle C, Mouroux J and Hofman P: Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer. 118:1726–1737. 2012. View Article : Google Scholar : PubMed/NCBI
31	Schiffmann LM, Fritsch M, Gebauer F, Günther SD, Stair NR, Seeger JM, Thangarajah F, Dieplinger G, Bludau M, Alakus H, et al: Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer. Br J Cancer. 120:69–78. 2019. View Article : Google Scholar : PubMed/NCBI
32	Rakaee M, Busund LT, Paulsen EE, Richardsen E, Al-Saad S, Andersen S, Donnem T, Bremnes RM and Kilvaer TK: Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer. Oncotarget. 7:72184–72196. 2016. View Article : Google Scholar : PubMed/NCBI
33	Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Küttner V, et al: Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 361:eaao42272018. View Article : Google Scholar : PubMed/NCBI
34	Taucher E, Mykoliuk I, Lindenmann J and Smolle-Juettner FM: Implications of the immune landscape in COPD and lung cancer: Smoking versus other causes. Front Immunol. 13:8466052022. View Article : Google Scholar : PubMed/NCBI

Journals